Literature DB >> 25356114

Interleukin 6 increases dysfunction of organs in sepsis rats through sirtuin 1.

Ying Ding1, Yongjun Lin2, Tao Zhu1, Man Huang2, Qiuping Xu2.   

Abstract

Sepsis-induced organ failure is the major cause of death, and is characterized by a massive dysregulated inflammatory response. The present study was to determine whether interleukin 6 (IL-6) expression was increased in sepsis rats and the roles of IL-6 in the damage of cardiac, liver and renal function in the sepsis rats. Sepsis rat models were elicited by intravenous injection of LPS. The mRNA and protein of IL-6 levels were increased in the sepsis rats. The Left ventricular developed pressure (LVDP) and average ±dP/dt were significantly reduced in sepsis rats compare with sham group. ALT and AST activities and creatinine level were increased in the sepsis rats. IL-6 significantly reduced LVDP and average ±dP/dt, increased the activities of ALT and AST, and increased the concentration of creatinine in the sepsis rats. EX527, a sirtuin 1 (SIRT 1) inhibitor, blocked the effects of IL-6 in the sepsis rats. These results indicate that IL-6 plays important roles in the damage of cardiac, liver and renal function in the sepsis rats through SIRT 1.

Entities:  

Keywords:  Interleukin 6; cardiac; liver; renal; sepsis; sirtuin 1

Year:  2014        PMID: 25356114      PMCID: PMC4211764     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Mitochondrial dysfunction and resuscitation in sepsis.

Authors:  Albert J Ruggieri; Richard J Levy; Clifford S Deutschman
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 2.  Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease.

Authors:  James L Bailey
Journal:  Kidney Int Suppl       Date:  2005-07       Impact factor: 10.545

Review 3.  How mitochondrial damage affects cell function.

Authors:  Andrew M James; Michael P Murphy
Journal:  J Biomed Sci       Date:  2002       Impact factor: 8.410

Review 4.  The current state of serum biomarkers of hepatotoxicity.

Authors:  Josef Ozer; Marcia Ratner; Martin Shaw; Wendy Bailey; Shelli Schomaker
Journal:  Toxicology       Date:  2007-12-05       Impact factor: 4.221

Review 5.  Cardiac dysfunction in severe sepsis and septic shock.

Authors:  Sergio L Zanotti-Cavazzoni; Steven M Hollenberg
Journal:  Curr Opin Crit Care       Date:  2009-10       Impact factor: 3.687

Review 6.  Mitochondrial mechanisms of sepsis-induced organ failure.

Authors:  Matthew C Exline; Elliot D Crouser
Journal:  Front Biosci       Date:  2008-05-01

7.  Alpha-lipoic acid attenuates lipopolysaccharide-induced kidney injury.

Authors:  Sang Heon Suh; Ko Eun Lee; In Jin Kim; Ok Kim; Chang Seong Kim; Joon Seok Choi; Hoon-In Choi; Eun Hui Bae; Seong Kwon Ma; Jong Un Lee; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2014-03-19       Impact factor: 2.801

8.  Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis.

Authors:  Ralph Lohner; Markus Schwederski; Carolin Narath; Johanna Klein; Georg D Duerr; Alexandra Torno; Pascal Knuefermann; Andreas Hoeft; Georg Baumgarten; Rainer Meyer; Olaf Boehm
Journal:  Mediators Inflamm       Date:  2013-07-02       Impact factor: 4.711

9.  The cardioprotective effect of hypertonic saline is associated with inhibitory effect on macrophage migration inhibitory factor in sepsis.

Authors:  Yi-Li Wang; Kwok-Keung Lam; Pao-Yun Cheng; Ching-Wen Kung; Shu-Ying Chen; Chun-Chih Chao; Hwong-Ru Hwang; Ming-Ting Chung; Yen-Mei Lee
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

10.  Long-term risk of sepsis among survivors of acute kidney injury.

Authors:  Edward Clark; Sean M Bagshaw
Journal:  Crit Care       Date:  2014-01-24       Impact factor: 9.097

View more
  1 in total

1.  Diagnostic performance of interleukin-6 and interleukin-8 for bacterial meningitis: a meta-analysis.

Authors:  Rong Yao; Yu Cao; Yao Chen; Zhi Zeng
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.